Ortho Clinical Diagnostics
QuidelOrtho Initiates Class III Device Recall for B12 Test Component
A specific lot number of the range verifier reagent for the B12 test yields erroneous results but does not affect assay performance.
QuidelOrtho Issues Class II Recall of Vitros Free T3 Calibrators
The calibrators may produce biased results, according to the US Food and Drug Administration, and QuidelOrtho's investigation is ongoing.
Abbott, Beckman Coulter, Thermo Fisher Scientific, Others Gain FDA Clearances in August
The clearances granted in August include hematology equipment, COVID-19 tests, a lupus test, and reagent packs to aid management of cancer patients.
QuidelOrtho Revenues up 8 Percent in Q2
On a conference call, its CEO said the future menu for the Savanna instrument will include respiratory panels, panels for other STDs, a panel for GI infections, and other tests.
QuidelOrtho Preliminary Q4 Earnings Beat Estimates
The firm expects its Q4 non-COVID core revenues to increase approximately 18 percent and full-year core revenues to increase approximately 11 percent.
Oct 12, 2022
QuidelOrtho Reports Preliminary Q3 Revenues
Aug 18, 2022
QuidelOrtho Board Authorizes $300M Share Repurchase
Aug 5, 2022
QuidelOrtho Q2 Revenues Rise 34 Percent
Jan 6, 2022